Results suggested that high expression of GLUT1 was associated with shorter overall survival in pancreatic cancer (fixed-effect model; HR = 1.469, 95% CI = 1.134–1.903, p = 0.004; I2 = 0%, p = 0.624). The gene discussed is SLC2A1; the disease is pancreatic neoplasm.